中文名称:(3aR,8aR)-(-)-(2,2-二甲基-4,4,8,8-四苯基四氢-[1,3]二氧戊环并[4,5-e][1,3,2]二氧杂膦庚烷-6-基)二甲胺
英文名称:(3aR,8aR)-(-)-(2,2-二甲基-4,4,8,8-四苯基四氢-[1,3]二氧戊环并[4,5-e][1,3,2]二氧杂膦庚烷-6-基)二甲胺
SMILES:CN(P1OC(c2ccccc2)(c2ccccc2)[C@H]2[C@H](C(O1)(c1ccccc1)c1ccccc1)OC(O2)(C)C)C
MDL:MFCD04117685
中文同义名:
(3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二氧并[4,5-E][1,3,2]二氧磷-6-YL)二甲胺; (3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁磷杂庚英-6-基)二甲基胺; (3AR,8AR)-四氢-N,N,2,2-四甲基-4,4,8,8-四苯基-1,3-二恶茂并[4,5-E][1,3,2]二氧磷杂七环-6-胺; (3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁膦杂庚英-6-基)二甲胺; (3AR,8AR)-(-)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二唑并[4,5-E][1,3,2]二磷杂庚英-6-基)二甲基胺; (3AR,8AR)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE(3AR,8AR)-(2,2-二; (3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二噁唑并[4,5-E][1,3,2]二噁膦杂庚英-6-基)二甲胺 100MG; (3AR,8AR)-(2,2-二甲基-4,4,8,8-四苯基-四氢-[1,3]二恶唑并[4,5-E][1,3,2]二噁磷杂庚英-6-基)二甲胺;
英文同义名:
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE; (3aR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TET& (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,min.98%; (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%; (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-<br>e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%; (3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosph; (11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-diMethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu; (3aR,8aR)-Tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine;